Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VL#FIA3-30 in Erectile Dysfunction
NCT02496845Phase 2Unknown
- Sponsor
- VasoLead
- Start
- Aug 2015
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of minoxidil and isosorbide dinitrate in erectile dysfunction (ED) (2 arms), sponsored by VasoLead. Primary endpoint: Number of participants with adverse events at 2 weeks. Status: unknown.
02
Drugs
minoxidilisosorbide dinitrate
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT02496845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02496845.